6AR-56455-45246
2 vaccinations
3 coded responses
17 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 980 / WA
- Registered
- 2021-11-07
- Relationship
- Child or adolescent in my care
- Guardian
- USC-13400-38579
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-07
Registered in v-safe
-
2021-11-07
Dose 1 — Pfizer-BioNTech
-
2021-11-07
Health check-in — day 0, dose 1, dependentFeeling: Good · Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-09
-
2021-11-10
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Muscle or body achesAdult check-in
- 2021-11-12
- 2021-11-13
- 2021-11-14
- 2021-11-21
-
2021-11-28
Dose 2 — Pfizer-BioNTech
-
2021-12-01
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Vulvovaginal swelling — Feeling: GoodFree text: Swollen VulvaMedDRA releases: 2024-11 · check-in free text available
- 2021-12-04
- 2021-12-05
- 2021-12-12
- 2021-12-19
- 2021-12-26
-
2022-01-02
Survey response — day 35, dose 2, dependentMedDRA: Ageusia, Dizziness, Fatigue, Headache, Oropharyngeal pain, Pyrexia, Rhinorrhoea, Throat irritation — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Lost of taste, runny nose, sore throat that started scratchy, headache, fatigue, dizzy, fever for a day.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-02
Report sent to call center — day 35, dose 2, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-07
- 2022-01-09
- 2022-01-12
- 2022-03-01
-
2022-05-29
Survey response — 6 months, dose 2, dependentMedDRA: COVID-19, Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: 2 colds and covidMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-07 | Pfizer-BioNTech | No |
| 2 | 2021-11-28 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-02 | Unsuccessful |
Free text
Release 10 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Swollen Vulva
Release 10 — day 35, dose 2, dependent
Symptoms: Lost of taste, runny nose, sore throat that started scratchy, headache, fatigue, dizzy, fever for a day.
Release 11 — 6 months, dose 2, dependent
Symptoms: 2 colds and covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
| SRO | Vulvovaginal swelling | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release